You are here: Industry Insights > Brand Story > DFE Pharma China Ltd - Exhibitor Webinar

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

DFE Pharma China Ltd - Exhibitor Webinar

PharmaSources.comJuly 24, 2020

Tag: Exhibitor Webinar , VEC , CPHI China

Favorites

Company Name: DFE Pharma China Ltd

Title： Anhydrous lactose and its benefits

Speaker: Pauline Janssen

Theme：Product Application Specialist

Pauline Janssen is a Product Application Specialist in OSD at DFE Pharma. She joined DFE Pharma beginning of 2017 and worked as a product developer on multiple OSD and DPI projects. As analytical expert, she supported in the design of experiments to understand products and its usage. Pauline holds a Master's Degree (cum laude) in Physical Chemistry from the Radboud University in Nijmegen, with an additional specialization in Science, Management and Innovation.

For more information, click here to view my store.

Previous:U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech

Next:ChemWerth Files its 500th Drug Master File with FDA

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

DFE Pharma China Ltd - Exhibitor Webinar | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

DFE Pharma China Ltd - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may like
More>>

DFE Pharma China Ltd - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may likeMore>>

You may like
More>>